Suppr超能文献

乳腺癌中肿瘤相关巨噬细胞和脂肪组织中的冠状结构。

Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.

机构信息

Department of Pathology, Yonsei University College of Medicine, Severance Hospital, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea.

出版信息

Breast Cancer Res Treat. 2018 Jul;170(1):15-25. doi: 10.1007/s10549-018-4722-1. Epub 2018 Feb 21.

Abstract

PURPOSE

We aimed to evaluate macrophage infiltration and to identify the status of crown-like structures (CLSs) in mammary adipose tissue of human breast tissue in cases with and without breast cancer.

METHODS

Breast adipose tissue was obtained from reduction mammoplasty (N = 56, Group 1), non-neoplastic breast tissue of breast cancer patients (N = 84, Group 2), and breast cancer with adipose stroma (N = 140, Group 3). Immunohistochemical staining of CD68 and CD163 was performed, and the infiltrating macrophages and CLSs within breast adipose tissue were evaluated.

RESULTS

Group 3 had the largest number of CD68-positive (CD68) and CD163-positive (CD163) macrophages and CLSs within adipose tissue (P < 0.001). Among Group 3, cases with high levels of CD68 and CD163 macrophages commonly had a higher histologic grade (P = 0.016 and P = 0.045), and cases with CD163 CLSs were correlated with old age (P = 0.042), estrogen receptor negativity (P = 0.013), human epidermal growth factor receptor-2 positivity (P = 0.043), and non-luminal A type (P = 0.039). Upon univariate analysis, high levels of CD163 macrophages were associated with shorter disease-free survival in node-negative breast cancer patients (P = 0.033), and CD68 CLSs were associated with shorter overall survival in node-positive breast cancer patients (P = 0.015).

CONCLUSIONS

CD68 and/or CD163 tumor-associated macrophage infiltration as well as CLSs are present in adipose tissue nearby the breast cancer lesion, and are associated with various clinicopathologic parameters of breast cancer.

摘要

目的

本研究旨在评估乳腺癌患者乳腺脂肪组织中巨噬细胞浸润的情况,并确定冠状结构(CLS)的状态。

方法

本研究从乳房缩小成形术(N=56,第 1 组)、乳腺癌患者非肿瘤性乳腺组织(N=84,第 2 组)和乳腺癌伴脂肪基质(N=140,第 3 组)中获取乳腺脂肪组织。进行 CD68 和 CD163 的免疫组织化学染色,并评估乳腺脂肪组织内浸润的巨噬细胞和 CLS。

结果

第 3 组脂肪组织中 CD68 阳性(CD68)和 CD163 阳性(CD163)巨噬细胞和 CLS 的数量最多(P<0.001)。在第 3 组中,CD68 和 CD163 巨噬细胞水平较高的病例通常具有较高的组织学分级(P=0.016 和 P=0.045),且 CD163 CLS 与高龄(P=0.042)、雌激素受体阴性(P=0.013)、人类表皮生长因子受体-2 阳性(P=0.043)和非腔 A 型(P=0.039)相关。单因素分析显示,CD163 巨噬细胞水平较高与淋巴结阴性乳腺癌患者无病生存率缩短相关(P=0.033),而 CD68 CLS 与淋巴结阳性乳腺癌患者总生存率缩短相关(P=0.015)。

结论

乳腺癌病灶附近的脂肪组织中存在 CD68 和/或 CD163 肿瘤相关巨噬细胞浸润和 CLS,并且与乳腺癌的各种临床病理参数相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验